FOR AUTHORS
Search
Search Results
Found 19 items.
-
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients
Published: 20 December 20121872PDF: 735 -
Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents
Published: 11 December 20122054PDF: 1139 -
Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
Published: 27 May 20132352PDF: 799 -
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
Published: 6 July 20182266PDF: 1172 -
Successful treatment of refractory adult onset Still’s disease with rituximab
Published: 16 December 20161884PDF: 1091 -
Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa
Published: 23 July 2020800PDF: 533 -
-
Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review
Published: 19 December 2023808PDF: 211 -
Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission
Published: 19 December 2023977PDF: 280 -
A short history of anti-rheumatic therapy - VII. Biological agents
Published: 9 November 20111252PDF: 1166 -
Polymyositis following varicella and mumps infection in adults: report of two cases
Published: 19 December 2023757PDF: 254 -
GISEA: an Italian biological agents registry in rheumatology
Published: 9 November 20111800PDF: 1413 -
Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis
Published: 19 December 2023914PDF: 221 -
B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab?
Published:1122PDF: 600 -
1 - 19 of 19 items